期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Potential importance of early treatment of SARS-CoV-2 infection in intestinal transplant patient: A case report
1
作者 Mathias Clarysse Laurens J Ceulemans +8 位作者 Lucas Wauters Nicholas Gilbo Viktor Capiau Gert De Hertogh Wim Laleman Chris Verslype Diethard Monbaliu jacques pirenne Tim Vanuytsel 《World Journal of Transplantation》 2022年第4期72-78,共7页
BACKGROUND Predispositions for severe coronavirus disease 2019(COVID-19)are age,immunosuppression,and co-morbidity.High levels of maintenance immunosuppression render intestinal transplant(ITx)patients vulnerable for ... BACKGROUND Predispositions for severe coronavirus disease 2019(COVID-19)are age,immunosuppression,and co-morbidity.High levels of maintenance immunosuppression render intestinal transplant(ITx)patients vulnerable for severe COVID-19.COVID-19 also provokes several gastroenterological pathologies which have not been discussed in ITx,so far.CASE SUMMARY During the second European COVID-19 wave in November 2020,an ITx recipient was admitted to the hospital because of electrolyte disturbances due to dehydration.Immunosuppression consisted of tacrolimus,azathioprine,and low-dose corticosteroids.During hospitalization,she tested positive on screening COVID-19 nasopharyngeal polymerase chain reaction swab,while her initial test was negative.She was initially asymptomatic and had normal inflammatory markers.Tacrolimus levels were slightly raised,as Azathioprine was temporarily halted.Due to elevated Ddimers at that time,prophylactic low-molecular weight heparin was started.Seven days after the positive test,dyspnea,anosmia,and C-reactive protein increase(25 mg/L)were noted.Remdesivir was administered during 5 d in total.High stomal output was noted in two consecutive days and several days thereafter.To exclude infection or rejection,an ileoscopy and biopsy were performed and excluded these.Four weeks later,she was discharged from the hospital and remains in good health since then.CONCLUSION Early eradication of severe acute respiratory syndrome coronavirus 2 in ITx recipients may be warranted to prevent acute rejection provocation by it. 展开更多
关键词 COVID-19 Intestinal transplantation OUTCOME SARS-CoV-2 Treatment Case report
下载PDF
FK506和供体特异性输血在大鼠异位心脏移植中的作用
2
作者 许敏 Milbhor D'silva +2 位作者 Yongxian Guo jacques pirenne Paul McMaster 《中华实验外科杂志》 CAS CSCD 北大核心 1999年第1期64-65,共2页
目的探讨FK506和供体特异性输血在大鼠异位心脏移植中的作用。方法利用大鼠异位心脏移植模型以了解在移植当天或移植术后第4日进行供者特异性输注(DST)的基础上,应用FK506能否延长移植物的存活。结果在移植当天行DST或单独用FK5061mg... 目的探讨FK506和供体特异性输血在大鼠异位心脏移植中的作用。方法利用大鼠异位心脏移植模型以了解在移植当天或移植术后第4日进行供者特异性输注(DST)的基础上,应用FK506能否延长移植物的存活。结果在移植当天行DST或单独用FK5061mg/kg连续10天,可将移植心中位存活时间从对照组的5天分别有效延长至7天和11天,而FK506与DST联合应用时并不产生增强效应。结论FK506和DST单独应用时虽均能延长大鼠同种移植心存活,但是它们没有协同作用。 展开更多
关键词 FK506 特异性输血 心脏移植 异位移植 大鼠
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部